The 26th edition of BioEquity Europe is the essential gathering for European growth-stage biotechnology companies seeking funding and strategic partnerships. Hundreds of biotechnology investors and pharmaceutical company representatives will be present to identify promising innovations and support their development. By participating in this event, you will gain exceptional visibility, meet international investment funds, and discuss optimal financing and internationalization strategies with industry experts.
As an Eurobiomed member, you benefit from a preferential rate. Contact Margot CONVERS-GOURHANT for any inquiries. Early Bird rates conclude on January 30.
Collective offer
Montpellier Méditerranée Métropole and the Région Sud, in partnership with Eurobiomed, offer 30% coverage of the costs associated with purchasing your pass. Places are limited, please do not hesitate to contact us promptly to verify your eligibility.
EN PARTENARIAT AVEC
AVEC LE SOUTIEN DE
